勤恳纸鹤
Lv3
388 积分
2025-01-08 加入
-
WS05.02 A Phase-1 multiple ascending dose healthy volunteer study to evaluate the safety, tolerability, and pharmacokinetics of GDC-6988, a dry powder formulation of a selective inhaled potentiator of TMEM16A
3天前
求助中
-
TMEM16A (ANO1) as a therapeutic target in cystic fibrosis
3天前
已完结
-
Neratinib after trastuzumab-based adjuvant therapy in patients with HER2-positive breast cancer (ExteNET): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial
3天前
已完结
-
The GLOBOCAN 2022 cancer estimates: Data sources, methods, and a snapshot of the cancer burden worldwide
7天前
已完结
-
Recent development of BTK-based dual inhibitors in the treatment of cancers
19天前
已完结
-
Discovery of a Novel 1,4-Benzodiazepine Derivative as a Highly Selective ANXA3 Degrader for the Treatment of Triple-Negative Breast Cancer
27天前
已完结
-
A Simple Approach to the Synthesis of 3-Substituted Rhodanines and Thiazolidine-2,4-diones
1个月前
已完结
-
Ivonescimab versus pembrolizumab for PD-L1-positive non-small cell lung cancer (HARMONi-2): a randomised, double-blind, phase 3 study in China
1个月前
已完结
-
Identification of 6-Fluorine-Substituted Coumarin Analogues as POLRMT Inhibitors with High Potency and Safety for Treatment of Pancreatic Cancer
1个月前
已完结
-
Mitochondrial Protease Targeting Chimeras for Mitochondrial Matrix Protein Degradation
1个月前
已完结